Tag: FreeStyle Libre
In brief: Carelon buys CareBridge, 20 reps sign letter, OIG adds reviews
November 1, 2024HME News Staff
INDIANAPOLIS – Carelon, a division of Elevance Health, recently entered into an agreement to acquire CareBridge, a value-based manager of home and community-based services for chronic and complex members that will serve as the foundation for its home health business, company officials announced during a conference call to discuss its third quarter 2024 financial results.
"We're excited to continue to serve all its customers and members,” said Gail Koziara Boudreaux,...
Beta Bionics integrates with Libre 3 Plus
October 31, 2024HME News Staff
IRVINE, Calif. – Beta Bionics has launched the integration of its flagship iLet Bionic Pancreas with Abbott’s FreeStyle Libre 3 Plus sensor. The iLet Bionic Pancreas is an autonomous insulin delivery system that streamlines diabetes management and is the first insulin delivery system in the United States to connect to Abbott’s FreeStyle Libre 3 Plus sensor, whose readings every minute will help iLet calculate insulin doses. “Beta Bionics continues to move at lightning speed...
FDA says OK to leave FreeStyle Libre CGMs on for imaging
October 30, 2024HME News Staff
ABBOTT PARK, Ill. – Users of the FreeStyle Libre 2 and 3 continuous glucose monitoring systems from Abbott no longer need to remove and discard the devices for imaging procedures, such as X-rays, CT scans and MRIs. The U.S. Food and Drug Administration has cleared the removal of the imaging contraindication, making Abbott’s systems the first and only patient-applied CGM sensors approved for these screenings. "For people with diabetes, especially those using insulin, removing a CGM...
Abbott recalls certain sensors
September 9, 2024HME News Staff
ABBOTT PARK, Ill. - Abbott has issued a recall for certain FreeStyle Libre 3 sensors due to a risk for inaccurate high glucose readings. On July 24, the company sent all affected customers an urgent medical device recall recommending they, among other things, immediately discontinue use and dispose of any affected sensors, and request a replacement for any affected seniors. Abbott initiated the recall after finding that a small number of FreeStyle Libre 3 sensors may provide incorrect high glucose...
In brief: MA payments, tech stage, device risk, Cardinal acquisition
February 2, 2024HME News Staff
WASHINGTON – CMS has released a Calendar Year 2025 Advance Notice for the Medicare Advantage and Medicare Part D Prescription Drug Programs that would pave the way for payments to MA plans to increase on average by 3.7%, or more than $16 billion, from 2024 to 2025.
“CMS continues to ensure that Medicare Advantage and Part D prescription drug plans remain strong, stable and affordable offerings,” said CMS Administrator Chiquita Brooks-LaSure. “The Advance Notice upholds...
ADS adds Libre 2 Plus sensor
January 31, 2024HME News Staff
CARLSBAD, Calif. — Advanced Diabetes Supply (ADS), a national distributor of diabetes devices under the ADS and US MED brands, is now carrying the new FreeStyle Libre 2 Plus sensor, the first DME provider in the country to offer consumers the 15-day sensor. “The FreeStyle Libre 2 Plus is an exciting advancement in diabetes health technology and is the only 15-day non-implantable continuous glucose monitoring (CGM) sensor in the U.S.,” said Bill Mixon, CEO of ADS. “As leading...
Abbott, WeightWatchers team up on new app
September 19, 2023HME News Staff
ABBOTT PARK, Ill., and NEW YORK – Abbott and WeightWatchers have announced the availability of a connected app to help people living with diabetes understand how food and activity impact their glucose levels. WW members who follow the WW Diabetes-Tailored Plan can now access their glucose data from Abbott’s FreeStyle Libre 2, a continuous glucose monitoring system, within their WW app. "Clinical data shows that healthy weight loss leads to a reduction of average glucose, which is important...
Medicare beneficiaries can now access FreeStyle Libre 3
August 4, 2023HME News Staff
ABBOTT PARK, Ill. – Abbott’s FreeStyle Libre 3 reader is now available to Medicare beneficiaries. The reader features a small, thin and discreet sensor, and can also be used by patients who may not have a compatible smartphone. "FreeStyle Libre continuous glucose monitoring systems are prescribed by more doctors for their Medicare patients than any other system," said Jared Watkin, senior vice president for Abbott's diabetes care business. "With recent coverage expansion, there are...
A Jonas, a CGM and a look to the future
April 19, 2023Theresa Flaherty, Managing Editor
One of the members of an online diabetes forum I’m in generated much excitement last week when she posted a pic comparing the size of her old FreeStyle Libre sensor with the latest generation, which is about a third of the original’s size.
“Wow!” “Amazing!” That was the general consensus.
Smaller in size means less noticeable (less face it, CGMs, while a thing of beauty in terms of technology and their impact on users’ lives, are not, well,...
Abbott issues voluntary correction for FreeStyle Libre devices
April 7, 2023HME News Staff
ABBOTT PARK, Ill. – Abbott in February initiated a voluntary medical device correction for its FreeStyle Libre, FreeStyle Libre 14 day and FreeStyle Libre 2 readers in the United States due to a limited number of reports (0.0017%) over several years of their lithium-ion batteries swelling, infrequently overheating or, in very rare cases, sparking or catching fire. No readers are being physically recalled and customers can continue to use their readers with the Abbott-provided USB cable and...